We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening.
- Authors
Cuiying Xie; Ancheng Gu; Khan, Muhammad; Xiangcao Yao; Leping Chen; Jiali He; Fumiao Yuan; Ping Wang; Yufan Yang; Yerong Wei; Fang Tang; Hualong Su; Jiamin Chen; Jinxia Li; Bohong Cen; Zhongyuan Xu
- Abstract
Hepatocellular carcinoma is one of the malignancies worldwide with a high mortality rate and an increasing incidence. Molecular Targeted agents are its common first-line treatment. Organoid technology, as a cutting-edge technology, is gradually being applied in the development of therapeutic oncology. Organoid models can be used to perform sensitivity screening of targeted drugs to facilitate the development of innovative therapeutic agents for the treatment of hepatocellular carcinoma. The purpose of this review is to provide an overview of the opportunities and challenges of hepatocellular carcinoma organoids in targeted drug sensitivity testing as well as a future outlook.
- Subjects
HEPATOCELLULAR carcinoma; MEDICAL screening; ORGANOIDS; DRUG development; DRUGS
- Publication
Frontiers in Oncology, 2023, Vol 12, p1
- ISSN
2234-943X
- Publication type
Article
- DOI
10.3389/fonc.2022.1105454